Showing results (901-910 of 1,492) with videos related to
Sort By:
Pageof 150
EFSA Journal. European Food Safety Authority|August 25, 2020
Evaluation of confirmatory data following the Article 12 MRL review and modification of the existing maximum residue levels for azoxystrobin, Maria Anastassiadou, Giovanni Bernasconi, et al.EFSA Journal. European Food Safety Authority|July 7, 2020
Review of the existing maximum residue levels for pyriofenone according to Article 12 of Regulation (EC) No 396/2005, Maria Anastassiadou, Alba Brancato, et al.EFSA Journal. European Food Safety Authority|July 7, 2020
Modification of the existing maximum residue levels for acequinocyl in citrus fruits, Maria Anastassiadou, Alba Brancato, et al.EFSA Journal. European Food Safety Authority|July 7, 2020
Evaluation of confirmatory data following the Article 12 MRL review for oryzalin, Maria Anastassiadou, Alba Brancato, et al.EFSA Journal. European Food Safety Authority|July 25, 2020
Modification of the existing maximum residue level for etofenprox in plums, Maria Anastassiadou, Giovanni Bernasconi, et al.EFSA Journal. European Food Safety Authority|April 29, 2025
Modification of the existing maximum residue level for chlormequat in oat, Giulia Bellisai, Giovanni Bernasconi, et al.EFSA Journal. European Food Safety Authority|April 17, 2025
Modification of the existing maximum residue levels and setting of import tolerances for trifloxystrobin in various crops, Giulia Bellisai, Giovanni Bernasconi, et al.EFSA Journal. European Food Safety Authority|July 31, 2025
Modification of the existing maximum residue levels for fenazaquin in strawberries, sweet peppers, tomatoes and aubergines, Giulia Bellisai, Giovanni Bernasconi, et al.Journal of Neuro-Oncology|December 12, 2012
Primary intracranial soft tissue sarcoma in children and adolescents: a cooperative analysis of the European CWS and HIT study groupsMartin Benesch, André O von Bueren, Tobias Dantonello, et al.The Journal of Clinical Investigation|July 1, 2021
Basophils balance healing after myocardial infarction via IL-4/IL-13Florian Sicklinger, Ingmar Sören Meyer, Xue Li, et al.Pageof 150